Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM
Diabetologia- Germany
doi 10.1007/s001250050613
Full Text
Abstract
Available in
Date
November 21, 1996
Authors
Publisher
Springer Science and Business Media LLC